Description:

Traditional treatment with eye drops for glaucoma can contribute to ocular surface disease (OSD). It is important that all clinicians treating glaucoma also diagnose and treat ocular surface disease to increase patient comfort and compliance, and prevent worsening OSD. We will review non-drop options such as SLT, intracameral implants and minimally invasive glaucoma surgery (MIGS) and how they fit into the treatment protocol for patients with glaucoma and OSD.

Course Code:

AOA381-GL

Speaker(s):

Ahmad Fahmy, O.D.

amfahmy1@gmail.com

Hardeep Kataria, O.D.

kataria.hardeep@gmail.com

Credits:

1

AOA Expiration Date:

3/13/2026

Related News

Ask the Coding Experts

You ask, the experts answer. The AOA Coding and Reimbursement Committee supports the AOA's strategic direction to develop and value procedural (CPT), diagnostic (ICD-10) and supply codes (HCPCS). Members can submit questions regarding medical records and coding to askthecodingexpert@aoa.org. Here are the latest questions.

AOA on Capitol Hill 2025: Live News Updates

Welcome to the official news hub for AOA on Capitol Hill 2025! Follow along with the AOA's exclusive coverage from optometry's single-largest federal advocacy event in Washington, D.C., and learn about the issues 600 of our colleagues championed on Capitol Hill.